Skip to main content
logo
InflaRx N.V. (FRA:IF0)
Germany flag Germany · Delayed Price · Currency is EUR
0.7950
+0.0395 (5.23%)
Last updated: Jan 28, 2026, 8:52 AM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Novel Therapeutic Products
179.33K
Novel Therapeutic Products Growth
162.93%

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
179.33K
United States Growth
162.93%